Advanced Therapy with Apomorphine Pump in Parkinson’s Disease

In ‘Advanced Therapy with Apomorphine Pump in Parkinson’s Disease,’ our panel explores the introduction of continuous subcutaneous apomorphine infusion as a treatment option for patients experiencing motor fluctuations despite optimized oral therapies. The expert neurologist outlines the clinical criteria for pump eligibility, including persistent OFF time and prior use of levodopa and adjunctive treatments. The discussion addresses practical considerations such as insurance approval, initiation of therapy, and dose titration, emphasizing that pump therapy is both accessible and manageable in real-world practice.

The patient shares a firsthand perspective on starting pump therapy, describing it as a meaningful turning point in managing Parkinson’s disease. Initial concerns about device use, appearance, and daily integration were balanced by improvements in symptom stability. The ability to reduce the burden of oral medication and achieve more consistent dopaminergic delivery resulted in fewer fluctuations and greater predictability throughout the day. This stability translated into increased confidence and the ability to re-engage in work, exercise, and social activities.

Practical insights into the initiation process highlight the importance of clinical support and caregiver involvement. The patient describes working with a nurse to determine the appropriate dose and adjust therapy over time. Questions about usability and daily routines were addressed through education and experience. The panel emphasizes that restoring predictability can help patients regain independence, reduce isolation, and improve overall quality of life.

Our next episode, ‘Parkinson’s Disease Impact on Daily Life and Family Burden,’ panelists will explore how OFF time disrupts independence, emotional well-being, and family life. The discussion highlights the real-world challenges patients face and the importance of support, communication, and self-advocacy.